| 23rd Apr 2019 7:00 am |
RNS |
SRA737 Phase I/IIa data to be presented at ASCO |
| 2nd Apr 2019 7:00 am |
RNS |
Preclinical Data for SRA737 Presented at AACR 2019 |
| 12th Mar 2019 7:00 am |
RNS |
Sareum Holdings PLC Issue of Options |
| 4th Mar 2019 7:00 am |
RNS |
HALF-YEARLY RESULTS ENDED 31 DECEMBER 2018 |
| 28th Feb 2019 2:04 pm |
RNS |
Sierra Oncology has reported its 2018 Results |
| 28th Feb 2019 8:14 am |
RNS |
New SRA737 preclin data to be presented at AACR |
| 23rd Jan 2019 1:38 pm |
RNS |
Sierra Oncology to present SRA737 at DDR Tx Summit |
| 18th Dec 2018 12:35 pm |
RNS |
Results of AGM |
| 18th Dec 2018 7:00 am |
RNS |
AGM Statement |
| 30th Nov 2018 11:17 am |
RNS |
Amendment to Preclinical Efficacy Announcement |
| 30th Nov 2018 7:45 am |
RNS |
Preclinical Efficacy for Immunotherapy Combination |
| 15th Nov 2018 10:24 am |
RNS |
Preclinical Data for SRA737 in Ovarian Cancer |
| 14th Nov 2018 7:00 am |
RNS |
AGM NOTICE |
| 13th Nov 2018 7:00 am |
RNS |
Directorate Change |
| 8th Nov 2018 12:28 pm |
RNS |
Sierra Oncology Q3 2018 Results |
| 26th Oct 2018 7:00 am |
RNS |
Completion of Placing |
| 1st Oct 2018 7:00 am |
RNS |
FINAL RESULTS FOR THE YEAR ENDED 30 JUNE 2018 |
| 27th Sep 2018 1:03 pm |
RNS |
Notice of Results |
| 26th Sep 2018 7:00 am |
RNS |
TYK2/JAK1 selected for certain cancers |
| 11th Sep 2018 7:00 am |
RNS |
Pre-Close Trading Statement |
| 10th Sep 2018 7:00 am |
RNS |
Selection of TYK2/JAK1 for autoimmune diseases |
| 9th Aug 2018 1:15 pm |
RNS |
Sareum notes Sierra Oncology Q2 2018 Results |
| 11th Jul 2018 9:38 am |
RNS |
Notification of PCA Shareholding |
| 15th Jun 2018 7:00 am |
RNS |
Advisers |
| 31st May 2018 7:00 am |
RNS |
Sareum regains rights to Aurora+FLT3 inhibitors |
| 10th May 2018 12:21 pm |
RNS |
SRA737 trial update in Sierra Oncology Q1 Results |
| 24th Apr 2018 7:00 am |
RNS |
Sareum to Present at BioTrinity 2018 in London |
| 17th Apr 2018 12:45 pm |
RNS |
AACR 2018 Update |
| 15th Mar 2018 7:00 am |
RNS |
Late-breaker abstract for SRA737 accepted for AACR |
| 13th Mar 2018 7:00 am |
RNS |
Interim Results |
| 27th Feb 2018 12:50 pm |
RNS |
Sierra Oncology expands SRA737 development program |
| 22nd Feb 2018 7:00 am |
RNS |
Preclinical synergy of sra737 and PARP inhibitor |
| 13th Feb 2018 7:00 am |
RNS |
Notice of Interim Results |
| 20th Dec 2017 11:00 am |
RNS |
Issue of Options |
| 19th Dec 2017 7:00 am |
RNS |
Patent Grants in Japan & China for TYK2 Inhibitors |
| 14th Dec 2017 11:01 am |
RNS |
Result of AGM |
| 14th Dec 2017 7:00 am |
RNS |
AGM Statement |
| 20th Nov 2017 7:00 am |
RNS |
Notice of AGM and Annual Report & Accounts |
| 14th Nov 2017 12:05 pm |
RNS |
Placing |
| 31st Oct 2017 7:00 am |
RNS |
Sierra Reports Preclinical Data for Chk1 Inhibitor |
